Literature DB >> 21777987

Cardiovascular biomarkers in acute Kawasaki disease.

Yuichiro Z Sato1, Delaram P Molkara, Lori B Daniels, Adriana H Tremoulet, Chisato Shimizu, John T Kanegaye, Brookie M Best, James V Snider, Jeffrey R Frazer, Alan Maisel, Jane C Burns.   

Abstract

BACKGROUND: Endomycocardial biopsies have demonstrated that subclinical myocarditis is a universal feature of acute Kawasaki disease (KD).
METHODS: We investigated biochemical evidence of myocardial strain, oxidative stress, and cardiomyocyte injury in 55 acute KD subjects (30 with paired convalescent samples), 54 febrile control (FC), and 50 healthy control (HC) children by measuring concentrations of cardiovascular biomarkers.
RESULTS: Levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and soluble ST2 (sST2) were elevated in acute vs. convalescent KD, FC, and HC (p≤0.002), while γ-glutamyl transferase and alanine amino transferase as measures of oxidative stress were increased in acute vs. FC (p≤0.0002). Cardiac troponin I (cTnI) levels, using a highly sensitive assay, were elevated in 30% and 40% of paired acute and convalescent KD subjects, respectively, and normalized within two years of disease onset. NT-proBNP and sST2 negatively correlated with deceleration time, but only NT-proBNP correlated with MV E:A ratio and internal diameter of the coronary arteries (RCA/LAD Zworst).
CONCLUSIONS: NT-proBNP and sST2 were elevated in acute KD subjects and correlated with impaired myocardial relaxation. These findings, combined with elevated levels of cTnI, suggest that both cardiomyocyte stress and cell death are associated with myocardial inflammation in acute KD.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777987      PMCID: PMC3253177          DOI: 10.1016/j.ijcard.2011.06.065

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  31 in total

1.  Migration of human monocytes in response to procalcitonin.

Authors:  Franz J Wiedermann; Nicole Kaneider; Petra Egger; Werner Tiefenthaler; Christian J Wiedermann; Karl H Lindner; Wolfgang Schobersberger
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

2.  Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children.

Authors:  Benjamin W Eidem; Colin J McMahon; Radha R Cohen; Jin Wu; Irina Finkelshteyn; John P Kovalchin; Nancy A Ayres; Louis I Bezold; E O'Brian Smith; Ricardo H Pignatelli
Journal:  J Am Soc Echocardiogr       Date:  2004-03       Impact factor: 5.251

3.  Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle.

Authors:  S Yonesaka; T Takahashi; T Matubara; T Nakada; H Furukawa; K Tomimoto; H Oura
Journal:  Jpn Circ J       Date:  1992-04

4.  Histopathological study on right endomyocardial biopsy of Kawasaki disease.

Authors:  C Yutani; K Okano; T Kamiya; K Oguchi; T Kozuka; M Ota; S Onishi
Journal:  Br Heart J       Date:  1980-05

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

6.  Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease.

Authors:  Takashi Kawamura; Masakuni Wago
Journal:  Cardiol Young       Date:  2002-03       Impact factor: 1.093

7.  Circulating cardiac troponin I levels in Kawasaki disease.

Authors:  P A Checchia; J Borensztajn; S T Shulman
Journal:  Pediatr Cardiol       Date:  2001 Mar-Apr       Impact factor: 1.655

8.  Expression and distribution of atrial natriuretic polypeptide in the ventricles of children with myocarditis and/or myocardial infarction secondary to Kawasaki disease: immunohistochemical study.

Authors:  T Fujiwara; H Fujiwara; G Takemura; M Mukoyama; Y Saito; K Nakao; H Imura; M Nakano; K Baba
Journal:  Am Heart J       Date:  1990-09       Impact factor: 4.749

9.  Diastolic function in children with Kawasaki disease.

Authors:  Elif Seda Selamet Tierney; Jane W Newburger; Dionne Graham; Annette Baker; David R Fulton; Steven D Colan
Journal:  Int J Cardiol       Date:  2009-11-28       Impact factor: 4.164

10.  Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.

Authors:  N Haneda; C Mori
Journal:  Acta Paediatr Jpn       Date:  1993-08
View more
  20 in total

1.  Cardiac biomarkers and acute kidney injury after cardiac surgery.

Authors:  Emily M Bucholz; Richard P Whitlock; Michael Zappitelli; Prasad Devarajan; John Eikelboom; Amit X Garg; Heather Thiessen Philbrook; Philip J Devereaux; Catherine D Krawczeski; Peter Kavsak; Colleen Shortt; Chirag R Parikh
Journal:  Pediatrics       Date:  2015-03-09       Impact factor: 7.124

2.  Multisystem Inflammatory Syndrome of a Neonate From a COVID-19-Infected Mother: A Case Report.

Authors:  Abdul Malek; Mukesh Khadga; Md Nurnobi Zahid; Sanjida Mojib; Reena Debnath; Sheela Khan; Mainul Haque; Brian Godman; Salequl Islam
Journal:  Cureus       Date:  2022-03-10

3.  Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.

Authors:  Seigo Okada; Hiroki Yasudo; Yuji Ohnishi; Chie Matsuguma; Reiji Fukano; Takahiro Motonaga; Takako Waniishi; Shunji Hasegawa
Journal:  Inflammation       Date:  2022-10-08       Impact factor: 4.657

4.  Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker.

Authors:  Rebecca Reindel; Kwang-Youn A Kim; Susan C Baker; Stanford T Shulman; Elizabeth J Perlman; Mark W Lingen; Cynthia Trevenen; Anne H Rowley
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

5.  Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.

Authors:  Mounika Reddy; Surjit Singh; Amit Rawat; Avinash Sharma; Deepti Suri; Manoj Kumar Rohit
Journal:  Rheumatol Int       Date:  2016-02-05       Impact factor: 2.631

6.  Kawasaki Shock Syndrome in a 12-Year-Old Girl Mimicking Septic Shock.

Authors:  Vindika Prasad Sinhabahu; Janani Suntharesan; Dimuthu Saraji Wijesekara
Journal:  Case Rep Infect Dis       Date:  2016-12-22

7.  Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.

Authors:  Alex Kentsis; Andrew Shulman; Saima Ahmed; Eileen Brennan; Michael C Monuteaux; Young-Ho Lee; Susan Lipsett; Joao A Paulo; Fatma Dedeoglu; Robert Fuhlbrigge; Richard Bachur; Gary Bradwin; Moshe Arditi; Robert P Sundel; Jane W Newburger; Hanno Steen; Susan Kim
Journal:  EMBO Mol Med       Date:  2012-12-20       Impact factor: 12.137

Review 8.  Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Authors:  Nagib Dahdah; Anne Fournier
Journal:  Diagnostics (Basel)       Date:  2013-01-10

9.  Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.

Authors:  Adriana H Tremoulet; Janusz Dutkowski; Yuichiro Sato; John T Kanegaye; Xuefeng B Ling; Jane C Burns
Journal:  Pediatr Res       Date:  2015-08-03       Impact factor: 3.756

10.  Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation.

Authors:  Benjamin Frank; Jesse Davidson; Suhong Tong; Blake Martin; Heather Heizer; Marsha S Anderson; Mary P Glode; Samuel R Dominguez; Pei-Ni Jone
Journal:  J Clin Exp Cardiolog       Date:  2016-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.